Dr. Alleva led the type 1 diabetes (T1D) immunotherapeutics’ program and portfolio for the Juvenile Diabetes Research Foundation (JDRF) from 2015 to 2017. Prior to his foundation work, he gained 15 years of experience leading drug discovery and development of small-molecules, biologics, and vaccine therapeutics for inflammatory, metabolic, angiogenic, infectious and autoimmune diseases (including T1D) at Emergent BioSolutions, Inc., Hollis-Eden Pharmaceuticals, XOMA, Ltd., and Neurocrine Biosciences, Inc. Dr. Alleva received a B.S. in biology from Indiana University and a Ph.D. in immunology from the Virginia Polytechnic Institute and State University.
Dr. Cannon is currently the founder, President and CEO of NovAb, Inc., which is developing a novel class of antibody biotherapeutics. He was formerly the President and CEO of Unigen Pharmaceuticals, the CEO of AerovectRx, the President and CEO of AdipoGenix; the founding CEO of Elixir Pharmaceuticals; a founder, director, and President of the Therapeutics Division of DyaxCorp and a founder, director and CSO of Hygeia Sciences. Ed earned his Ph.D. in biochemistry from the University of Georgia, and studied molecular immunology at Harvard Medical School.
Ms. Davis is currently a Director at Brooks Automation (BRKS), which is a global leader in robotics and a Director at CRA Health, a privately-held predictive analytics firm. Since 2000 she has been a Managing Director of Angel Healthcare Investors, overseeing its investment process in early-stage firms, serving on boards of portfolio companies and actively contributing to fundraising and successful portfolio company exits. Robyn earned her B.A. from Tufts University and her M.B.A. from Harvard University.
Dr. Atkinson is the American Diabetes Association Eminent Scholar for Diabetes Research and the Jeffrey Keene Family Professor at the University of Florida. He is also the Executive Director of the Network for Pancreatic Organ donors with Diabetes (nPOD). The author of over 400 publications, he is one of the world’s most cited diabetes researchers and received the prestigious Eli Lilly Award for Outstanding Scientific Achievement from the American Diabetes Association. Dr. Atkinson earned his Ph.D. from the Department of Pathology at the University of Florida and his B.S. in microbiology from the University of Michigan – Dearborn.
Dr. Thomas is a Professor of Medicine and Director of the Division of Rheumatology and Immunology at the Vanderbilt University Medical Center and a fellow of the American Association for the Advancement of Science. He was a faculty member at the Baylor College of Medicine. Dr. Thomas earned his B.A. from Southwestern at Memphis, his M.D. from the University of Tennessee and was a Postdoctoral Fellow at Washington University Medical Center.